Randomised, phase 1, dose-finding study of MEDI416...
Dose-finding study: PCK9 MAb/GLP-1 analogue fusion molecule
-->
Metabolism disorders occur when the body’s normal metabolic processes are disrupted. Explore our articles, news, literature reviews, tips, and more on metabolism disease research.
Dose-finding study: PCK9 MAb/GLP-1 analogue fusion molecule
SERP1: a new GLP-1 receptor interactor
Measuring IP-One to assess autoimmune hypoparathyroidism
Validation of HTRF Cortisol with either 11beta-HSD1 or 11beta-HSD2 for s...
In vitro inhibitory activity of 11β-HSD1assessed with the use of a HTRF...
In vitro inhibition activity of 11 beta -HSD1 assessed by the HTRF cort...
11β-HSD1 inhibition is a potential therapeutic target for a broad range...
Cortisol levels monitored by HTRF assay
Development of a cell-based assay for measuring 11beta-HSD1 activities u...